Does ENTRECTINIB Cause Interstitial lung disease? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Interstitial lung disease have been filed in association with ENTRECTINIB (Rozlytrek). This represents 0.9% of all adverse event reports for ENTRECTINIB.
13
Reports of Interstitial lung disease with ENTRECTINIB
0.9%
of all ENTRECTINIB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Interstitial lung disease From ENTRECTINIB?
Of the 13 reports, 4 (30.8%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENTRECTINIB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does ENTRECTINIB Cause?
Dizziness (143)
Off label use (137)
Death (126)
Disease progression (105)
Taste disorder (68)
No adverse event (65)
Constipation (60)
Fatigue (60)
Drug ineffective (58)
Blood creatinine increased (57)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ENTRECTINIB Alternatives Have Lower Interstitial lung disease Risk?
ENTRECTINIB vs ENZALUTAMIDE
ENTRECTINIB vs EPCORITAMAB
ENTRECTINIB vs EPCORITAMAB-BYSP
ENTRECTINIB vs EPERISONE
ENTRECTINIB vs EPHEDRINE